TASE:HARL
TASE:HARLInsurance

Assessing Harel Insurance (TASE:HARL) Valuation Following New Share Buyback Announcement

Harel Insurance Investments & Financial Services (TASE:HARL) just unveiled a share buyback program authorized by its Board of Directors. The company aims to repurchase up to ILS 100 million of its own shares using internal funds through October 2027. See our latest analysis for Harel Insurance Investments & Financial Services. The buyback news comes after a remarkable run for Harel Insurance Investments & Financial Services. Investor enthusiasm has sent the share price up 138% year-to-date...
TASE:SAE
TASE:SAEConsumer Retailing

Middle Eastern Dividend Stocks To Consider In November 2025

As most Gulf markets track Asian shares higher, bolstered by stronger-than-expected U.S. economic data, investors are increasingly eyeing the Middle East for its potential in dividend-yielding stocks. In this dynamic landscape, a good dividend stock is often characterized by a consistent payout history and resilience amid fluctuating market conditions.
TASE:TASE
TASE:TASECapital Markets

Could Tel Aviv Stock Exchange’s (TASE:TASE) New Real Estate Index Reshape Sector Investment Strategies?

The Tel Aviv Stock Exchange announced the upcoming launch of the TA-Real Estate 35 index, which will track the largest 35 real estate companies out of 89 currently listed, covering nearly 80% of the sector's market capitalization and debuting on November 9, 2025. This move highlights a significant development in broadening investment benchmarks for real estate on TASE, where the sector comprises about 18% of total market capitalization but is currently followed by relatively low indexed...
TASE:SOFW
TASE:SOFWMedical Equipment

SofWave Medical (TASE:SOFW) Losses Narrow 16.6% Annually, Valuation Raises Investor Debate

SofWave Medical (TASE:SOFW) continues to operate at a net loss, but has trimmed those losses by an average of 16.6% per year over the last five years. While profitability remains out of reach, its profit margin trajectory shows steady improvement, appealing to investors looking for signs of operational progress. With ongoing growth in profit or revenue as the primary reward, the company’s results set the stage for further scrutiny from those weighing its loss reduction against premium pricing...